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In cardiac neural-crest-ablated embryos, the secondary heart field fails to add myocardial cells to the outflow tract and elongation of the tube is
deficient (Yelbuz, T.M.,Waldo, K.L., Kumiski, D.H., Stadt, H.A.,Wolfe, R.R., Leatherbury, L., Kirby,M.L., 2002. Shortened outflow tract leads to
altered cardiac looping after neural crest ablation. Circ. Res. 106, 504–510). Since that study,we have shown that the secondary heart field provides
both myocardium and smooth muscle to the arterial pole (Waldo, K.L., Hutson, M.R.,Ward, C.C., Zdanowicz, M., Stadt, H.A., Kumiski, D., Abu-
Issa, R., Kirby,M.L., 2005. Secondary heart field contributesmyocardium and smoothmuscle to the arterial pole of the developing heart. Dev. Biol.
281, 78–90). The present study was undertaken to determine whether addition of both cell types is disrupted after neural crest ablation. Marking
experiments confirm that themyocardial component fails to be added to the outflow tract after neural crest ablation. The cells destined to go into the
outflowmyocardium fail tomigrate and are left at the junction of the outflowmyocardiumwith the nascent smoothmuscle at the base of the arterial
pole. In contrast, the vascular smooth muscle component is added to the arterial pole normally after neural crest ablation.When the myocardium is
not added to the outflow tract, the point where the outflow joins the pharynx does not move caudally as it normally should, the aortic sac is smaller
and fails to elongate resulting in abnormal connections of the outflow tract with the caudal aortic arch arteries.
D 2005 Elsevier Inc. All rights reserved.Keywords: Heart development; Outflow tract; Arterial pole; Myocardium; Smooth muscle; Cardiac neural crest ablation; Secondary heart fieldIntroduction
Cardiac neural crest cells migrate into pharyngeal arches 3,
4, and 6, and from there, a subpopulation migrates into the
cardiac outflow tract to participate in division of the outflow
into pulmonary and aortic vascular channels. In addition to this
direct role in cardiac development, the crest cells also have an
indirect role by modulating pharyngeal FGF signaling (Farrell
et al., 2001). In mice, FGF8 signaling appears to be critical for
development of structures in the pharynx, as well as the heart.
An Fgf8 hypomorphic allele coupled with a null allele results
in phenotypic changes in the developing pharynx and heart
that mimic cardiac neural crest ablation in the chick suggesting0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.02.011
T Corresponding author. Fax: +1 919 668 1599.
E-mail address: mlkirby@duke.edu (M.L. Kirby).that FGF8 signaling in the pharynx is important for normal
heart development in several species (Abu-Issa et al., 2002;
Frank et al., 2002; Hutson and Kirby, 2003).
Another indirect effect of cardiac neural crest ablation is
failure of elongation of the outflow tract from the secondary
heart field (Yelbuz et al., 2002, 2003). Failure of outflow
elongation has also been characterized in the Fgf8 hypo-
morphic mouse. It has been known for many years that the
outflow tract elongates by addition of cells from an
extracardiac population (De la Cruz et al., 1977), but it is
only recently that the source of these cells has been described
in both chick and mouse (Kelly et al., 2001; Mjaatvedt et al.,
2001; Waldo et al., 2001). Waldo et al. (2001) used marking
experiments and quail-chick chimeras to show that cells in the
pharyngeal mesenchyme caudal to the outflow tract are added
to the elongating outflow tract. Using different marking281 (2005) 66 – 77
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conotruncal myocardium is derived from an anterior heart
field which they defined as pharyngeal mesenchyme imme-
diately adjacent and surrounding the distal end of the heart
tube. An anterior heart field was identified in mice by Kelly et
al. (2001), who used a lacZ transgenic insertion into the
mouse Fgf10 locus. In this case, lacZ expression was found in
the entire outflow tract and right ventricle (Kelly et al., 2001;
Zaffran et al., 2004).
In a previous study, we traced secondary heart field cells
by marking them with a combination of DiI and rhodamine at
stages 14/15, when elaboration of the distal outflow tract
myocardium was initiated, and stages 18/20, when outflow
elongation should have ceased (Waldo et al., 2005). Two
groups of cells moved from the secondary heart field to the
arterial pole. The early group of marked cells added
myocardium by moving to the contralateral side of the
outflow tract myocardium within 48 h. The second group of
cells, marked at later stages were found on the ipsilateral
caudal wall of the aortic sac distal to the myocardial edge
where vascular smooth muscle markers were expressed.
These results showed that the secondary heart field provides
both myocardium and vascular smooth muscle to the arterial
pole of the heart. Furthermore, the smooth muscle tunic of the
aorta and pulmonary trunk was derived from two popula-
tions: distally from cardiac neural crest cells and proximally
from the secondary heart field. This meant that there were two
seams where cells abutted in the arterial pole. The first was at
the myocardial junction with secondary heart field-derived
vascular smooth muscle and the second was between the
secondary heart field-derived vascular smoothmuscle and the
cardiac neural crest-derived vascular smooth muscle.
In this study, we investigated what effect cardiac neural
crest ablation has on the vascular smooth muscle and
myocardial populations derived from the secondary heart
field. We marked the secondary heart field cells in embryos
after neural crest ablationwithDiI/rhodamine, and follow their
migration over time. We examined the myocardial-to-smooth
muscle junction in the arterial pole using vascular smooth
muscle, myocardial, and endothelial cell markers in chick and
quail embryos. Cardiac neural crest ablation disrupts develop-
ment of the arterial pole by interfering with addition of the
myocardium but not the smooth muscle derived from the
secondary heart field. Normally, as the myocardium is added,
the outflow tract moves caudally along the ventral pharynx and
this movement does not occur after neural crest ablation. As a
result, the junction of the outflow tract with the pharynx is
abnormal and the formation of the most caudal aortic arch
arteries is disrupted. Rather than migrating into the outflow
tract and differentiating into myocardium, the progenitor
population in the secondary heart field undergoes excessive
proliferation in the floor of the pharynx which perturbs the
junction of vascular smoothmuscle withmyocardium. Finally,
failure of addition of the myocardial contribution from the
secondary heart field results in disrupted patterning of the
arterial pole.Materials and methods
Neural crest ablation
Cardiac neural crest-ablated and sham-operated embryos
were prepared as described previously (Waldo et al., 1999).
Embryos were collected at stages 12, 14, 16 18, 22, and at
day 8.
Secondary heart field cell tracing
Cell tracing was performed as previously described
(Waldo et al., 2005)R
Cell proliferation
5-Bromo-2Vdeoxyuridine (BrdU, 20 Al of a 40-mM solu-
tion, Boehringer) was applied to the chick embryos 1 h before
fixation in 4% paraformaldehyde in PBS as reported by
Brand-Saberi et al. (1995). Fixation was carried out overnight
followed by paraffin embedding, sectioning, and immuno-
histochemical processing. The number of BrdU-positive cells
was counted in populations of 100 cells in transverse and
sagittal sections.
Immunohistochemistry
The embryoswere embedded in paraffin, sectioned at 8 Am
and processed as described previously (Waldo et al., 1998;
Waldo et al., 2005) to visualize HNK1, MF20, QH-1, myosin
light chain kinase (MLCK), alpha smooth muscle actin
(aSMA), anti-rhodamine and BrdU. The preparations were
counterstainedwith hematoxylin (Anatech,BattleCreek,MI).
In situ hybridization
Cloning, probe preparation, and in situ hybridization for
SM22 andNkx2.5were described in detail previously (Waldo
et al., 2001, 2005). After examination and documentation of
whole-mount staining, the embryos were embedded, in 15%
sucrose and 7.5% gelatin, frozen and cryo-sectioned at 12 Am
and mounted.Results
Cardiac neural crest ablation disrupts the myocardial but
not the smooth muscle contribution to the arterial pole from
the secondary heart field
We have recently reported that the secondary heart
field first adds myocardium and later smooth muscle to
the arterial pole (Waldo et al., 2005). To follow the
addition of the secondary heart field cells to the arterial
pole in neural crest-ablated embryos more closely, we
labeled the secondary heart field of neural crest-ablated
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observed the movement and differentiation of the labeled
cells over the next 72 h. In the sham-operated embryos,
migration of the myocardial component at stages 14–18
was followed by movement of the smooth muscle
component at stages 22–26 as reported previously (Waldo
et al., 2005). When the secondary heart field was labeled in
neural crest-ablated embryos at stage 14 (Fig. 1A), the
labeled cells never moved beyond the distal rim of the
myocardium after 48 h (arrow in Fig. 1B). The secondary
heart field cells never added myocardium to the outflow in a
spiral as described in normal embryos (Waldo et al., 2005;
Ward et al., submitted). The labeled cells were clumped at
the junction of the outflow tract with the ventral pharynx
(arrow in Fig. 1C) and were not, for the most part,
incorporated into the outflow myocardium. This was seen
in 5 of 6 neural crest-ablated embryos. When secondary
heart field was labeled with DiI/rhodamine in neural crest-
ablated embryos at stage 21 (Fig. 1D), the smooth muscle
component was added to the caudal wall of the aortic sac
(arrow in Figs. 1E–F) and was beginning to express alpha
smooth muscle actin (aSMA), a marker of smooth muscle
differentiation, but showed no expression of MF20 (Fig.
1G). This was seen in 4 of 4 neural crest-ablated embryos.
These results show that the myocardial cells derived from
the secondary heart field are not added to the outflow
myocardium after neural crest ablation confirming the report
by Yelbuz et al. (2002), and further show that the vascular
smooth muscle is added normally.Fig. 1. The myocardial but not the smooth muscle population of the secondary he
heart field of neural crest-ablated embryos were labeled at stage 14 (A–C) and sta
injection at stage 14; labeled cells located caudal to outflow tract. (B) 48 h follow
Sagittal section of the cardiac outflow and aortic sac region (in B) immunostained
distal to the myocardial rim (arrow). (D) At the time of the injection, labeled cells
are in the smooth muscle of the caudal wall of the aortic sac (arrow). (F) Sagittal se
identify labeled DiI/rhodamine-labeled cells (arrow) and MF20 (green) to identify
cells in aortic sac). The majority of the labeled secondary heart field cells are clearl
expressed (arrow).Outflow tract fails to move caudally after neural crest
ablation
Comparison of sagittal sections from sham-operated and
cardiac neural crest-ablated embryos at progressively later
stages showed that the outflow tract of crest-ablated embryos
was not moving caudally with respect to the pharyngeal
arches. This was obvious by the relationship of the
pharyngeal arch arteries to the position of the outflow tract.
Frequently, the arch arteries were malaligned with respect to
the lumen of the outflow tract. The degree of malalignment
was variable and unpredictable but was most noticeable at
stages 24–26 when the outflow tract is normally positioned
between pharyngeal arch arteries 4 and 6 in sham-operated
embryos (Figs. 2A, B). In neural crest-ablated embryos, the
outflow tract was aligned with the 3rd or 4th arch artery
(Figs. 2C, D), and the lumen of the 4th arch artery was
frequently enlarged (Fig. 2D). Due to this misalignment of
the outflow tract with the arch arteries, the flow of blood
often took a zig-zag pathway (Figs. 3A–C).
Secondary heart field cells proliferate excessively after
neural crest ablation
After neural crest ablation, the secondary heart field fails
to add the myocardial component to the arterial pole
between stages 14 and 18. We wanted to know if the cells
were dying. TUNEL assay showed very little cell death in
the secondary heart field in either the sham-operated orart field is affected by cardiac neural crest ablation. Cells of the secondary
ge 21 (D–G) with a mixture of DiI and rhodamine (red). (A) 4 h following
ing injection; labeled cells distal to outflow tract myocardium (arrow). (C)
with rhodamine antibody to identify DiI/rhodamine-labeled cells which are
were caudal to the distal outflow tract. (E) 48 h after injection, labeled cells
ction from the embryo in E immunostained with rhodamine antibody (red) to
myocardial cells. (G) The section in F was relabeled with aSMA (dark gray
y located in the caudal wall of the aortic sac where aSMA is beginning to be
Fig. 2. Cardiac neural crest-ablation disrupts the caudal movement of the
outflow tract relative to the pharyngeal arches and its alignment with the
aortic arch arteries. MF20 fluorescent images of labeled myocardium
(yellow) have been superimposed on sagittal DIC images of the distal
outflow tract and pharyngeal arches. The pharyngeal arch arteries are
indicated by numbers and the pouches by P accompanied by a number. (A)
Normal alignment of the outflow tract lumen at stage 24 compared with
alignment in cardiac neural crest-ablated embryo (C) in which the lumen is
aligned with the third arch artery. The second arch artery (2) is still open at a
time when it should no longer be present, and the 4th and 6th arch arteries
are absent (white arrows). By stage 25, the lumen of the outflow tract of a
sham embryo (B) is aligned with the 4th and 6th arch arteries. In contrast,
the lumen of a neural crest-ablated outflow tract (D) is aligned with an
abnormally large 4th arch artery.
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not shown). BrdU incorporation in sham-operated (n = 40)
and neural crest-ablated (n = 41) embryos was used to
assess proliferation in the secondary heart field during
stages 12–22. Proliferation was significantly increased in
the secondary heart field of cardiac neural crest-ablated
embryos between stages 14 and 18 (Figs. 4A–E), coincid-
ing with the time during which the myocardial component
of the secondary heart field is normally added. At stage 16,
proliferation in the outflow myocardium of the neural crest-
ablated embryos was elevated to a similar extent while the
ventricular myocardium showed slightly less elevated
proliferation. By stage 18, proliferation in the secondaryFig. 3. Abnormal connections of aortic arch arteries with the outflow tract in cardi
the same neural crest-ablated embryo were superimposed on DIC sagittal sections.
fourth arch artery causing the outflow tract lumen to have a zig-zag connection wheart field of neural crest ablated embryos reached a peak of
300% over control, while proliferation in outflow and
ventricular myocardium were decreasing to more normal
values (Table 1). At stage 22, when cardiac looping and
elongation were complete, there was another increase in
proliferation of the secondary heart field in both the sham-
operated and cardiac neural crest-ablated embryos (Figs.
4A, F, G). The increased proliferation was associated with
re-initiation of HNK-1 expression in the secondary heart
field. HNK-1 is associated with cell migration and its re-
expression suggests a second wave of movement by the
secondary heart field cells that is not disrupted by neural
crest-ablation (arrow in Figs. 5A, B). Based on our results
from the tracing experiments and from the proliferation data
discussed above, the HNK-1 re-expression in the secondary
heart field is associated with the generation of vascular
smooth muscle cells from the secondary heart field. Because
both sham-operated and neural crest-ablated embryos
showed the increased proliferation and re-expression of
HNK-1, it is likely that the smooth muscle component
added by the secondary heart field is normal after neural
crest ablation. This further suggests that only the myocardial
addition from the secondary heart field is disrupted after
neural crest ablation.
Abnormal junction of the outflow tract with the pharynx
The secondary heart field cells in neural crest-ablated
embryos are proliferating and have the potential to
become cardiomyocytes as evidenced by equivalent
expression of Nkx2.5 in both sham-operated and cardiac
neural crest-ablated embryos (Supplement, Fig. 1). We
examined the secondary heart field cells that remain near the
aortic sac of experimental embryos for the myocardial
marker, MF20. Sham-operated (n = 57) and cardiac neural
crest-ablated (n = 64) embryos were collected at alternating
stages between HH14-28 and immunostained with MF20 in
whole mount and sagittal sections.
The distal border of the outflow myocardium of crest-
ablated embryos was flattened and failed to form in the
typical saddle-shape seen in the sham-operated embryos
(compare Figs. 6A and B and 6C and D). This saddle-shapedac neural crest-ablated embryos at stage 26. Fluorescent MF20 images from
(A–C) The outflow tract has failed to move caudally and is aligned with the
ith the lumen of the fourth arch artery.
Table 1
Increased proliferation in secondary heart field and outflow and ventricular
myocardium after neural crest ablation
Stage SHF Average of inner and outer curvature
OFT Ventricle
16 sham 17 13.5 21
16 NCA 29 (j 71%) 23 (j 70%) 32 (j 52%)
18 sham 6 19.5 27.5
18 NCA 24 (j 300%) 25.5 (j 31%) 31.5 (j 14%)
Number indicates the average number of cells per 100 counted that
incorporated BrdU during a 60-min incubation. At least 500 cells were
counted for each region.
Fig. 5. Reexpression of HNK-1 at stage 22 coincides with generation of
secondary heart field-derived vascular smooth muscle. Sagittal sections of
the arterial pole were stained with MF20 (red) to identify the myocardium
and HNK-1 to identify migrating cells (green). (A, B) Re-expression of
HNK-1 at stage 22 in the secondary heart field (arrows) of sham and cardiac
neural crest-ablated embryos.
Fig. 4. The secondary heart field experiences two waves of proliferation.
(A) The first wave of proliferation occurs during looping and reaches a peak
at stage 16 whereas a second wave occurs at stage 22 even though the
outflow tract no longer undergoes elongation. After cardiac neural crest-
ablation, the secondary heart field cells undergo significantly (*) increased
proliferation between stages 14 and 18. Proliferation decreased at stage 18
in the sham-operated but not in neural crest-ablated embryos. At stage 22,
the elevation in proliferation in cardiac neural crest-ablated embryos was not
significantly compared to shams. (B–E) Transverse sections stained with
antiBrdU at stage 15+ and 16. Proliferation was elevated in the secondary
heart field of the neural crest-ablated embryos (C, E) compared to the shams
(B, D). (F, G) Stage 22 sagittal sections stained with antiBrdU. Proliferation
was elevated in secondary heart field of both the sham and cardiac neural
crest-ablated embryos. Arrow points to the secondary heart field.
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dium to the vascular smooth muscle at the base of the nascent
aorta and pulmonary trunk. Furthermore, the distal edge of
the myocardial cuff (Figs. 6A–D) was closer to the pharynx
in the cardiac neural crest-ablated embryos compared to the
shams (compare Figs. 6C and D). This resulted in shortening,
or failure of elongation, of the aortic sac region in the cardiac
neural crest-ablated embryos (double-headed arrows in Figs.
6C and D). In approximately 40% (14/35 between stages 22
and 26) of the neural crest-ablated embryos, the caudal part of
the distal outflow tract and adjoining aortic sac was deformed
on one or both sides by bulges that were first recognized at
stage 20 and became most prominent at stages 22–24(asterisks or arrows in Figs. 7A–BV). These bulges were
never observed in sham-operated embryos. The walls of these
bulges were 30–80% positive for MF20 (white arrows in
Figs. 7C, D). Each bulge was partially filled with cardiac jelly
and displaced MF20-positive cells. A smaller percentage of
embryos had a series of small interconnecting bulges that
gave the caudal outflow tract and adjoining aortic sac area a
rippled appearance (Fig. 7E, see also Fig. 2C). The bulges
extended into the secondary heart field and were directed
inward toward the lumen of the aortic sac, or dorsolaterally
toward a pharyngeal pouch (green arrows in Figs. 7C–E). In
some of these cases, an arch artery (usually the 4th or 6th) was
pinched off from the aortic sac by a constriction caused by
secondary heart field cells directed toward a 3rd or 4th
pharyngeal pouch (Fig. 7E).
In crest-ablated embryos without bulges, the caudal distal
edge of the myocardial rim was deformed or thickened by
inwardly displaced finger-like extensions of MF20-positive
cells (arrows in Fig. 7G) usually directed toward the outflow
tract lumen. These deformations differed dramatically from
the normal myocardial rim (arrow in Fig. 7F) seen in sham-
operated embryos (compare Figs. 7F and G). Sometimes
MF20-positive cells were displaced into the subendothelial
layer of the caudal aortic sac that eventually becomes the base
of the aorta (arrows in Fig. 7H). In addition, because the distal
edge of the myocardium failed to regress in cardiac neural
Fig. 6. Abnormal myocardial-smooth muscle junction following cardiac neural crest ablation. Whole mount embryos stained with MF20, a myocardial marker.
(A, C) Sham-operated embryos. (B, D) Cardiac neural crest-ablated embryos. At stages 24 and 25, the distal myocardial edge of the outflow tract is flattened in
cardiac neural crest-ablated embryos (B, D) and does not achieve the typical saddle-shaped configuration normally seen in sham-operated embryos (A, C).
Because the myocardial rim (in D) is more cranially located than normal in the cardiac neural crest-ablated embryos, the adjacent aortic sac region is
abnormally shortened (double headed arrow in D). In contrast, the distal myocardial edge (in C) of the sham embryo is located more caudally and the aortic sac
region is elongated (double-headed arrow in C).
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part that will become the proximal vascular smooth muscle
wall of the pulmonary trunk, was abnormally shortened
(compare Figs. 7J and K).
Vascular smooth muscle markers are disrupted by cardiac
neural crest-ablation during development of the arterial
pole
To determine whether differences exist in the smooth
muscle component derived from the secondary heart field in
neural crest-ablated embryos, we examined 36 sham-oper-
ated and 32 neural crest-ablated embryos between stages 20
and 28 for smooth muscle marker expression. SM22, an early
marker of vascular smooth muscle differentiation was
examined by in situ hybridization in stage 27 whole mount
embryos. By stage 27, SM22 expression was high at the
ventriculoarterial junction and on the right side of the aortic
sac in sham-operated embryos (arrows in Figs. 8A, B, G).
After cardiac neural crest ablation, SM22 expression was
detected in all the tissue surrounding the aortic sac (arrows in
Figs. 8D–H).
In order to examine the expression of other vascular
smooth muscle markers in the arterial pole in cardiac neural
crest-ablated embryos, we collected chick and quail embryos
at alternating stages between HH22 and 28 and stained with
antibodies to aSMA or MLCK. At all the developmentalstages observed, cardiac neural crest ablation affected the
expression patterns of aSMA and MLCK in a number of
ways. Although the subendothelial expression of aSMA and
MLCK was not strongly affected by neural crest ablation, the
expression of these smooth muscle markers in the mesen-
chymal tissues adjacent to, or surrounding the aortic sac was
profoundly affected.Most often, theaSMAexpression tended
to be ectopic and disorganized (compare aSMA-positive
mesenchyme in Figs. 9A andB).As shown previously,aSMA
is associated with neural crest cells at stages 22–28 and is not
normally expressed by smooth muscle cells derived from the
secondary heart field until stages 28–29 (Waldo et al., 2005).
At late stage 28, an area in the proximal wall of the aorta and
pulmonary trunk that had been aSMA-negative in earlier
stages was aSMA-positive in both sham-operated and cardiac
neural crest-ablated embryos (compare Figs. 9C with D). This
is the region of smooth muscle derived from the secondary
heart field (Waldo et al., 2005). In contrast MLCK was
expressed in the same regions as in sham-operated embryos
(arrow in Figs. 9F and H).
The aortic sac is diminished in size and does not elongate
which results in abnormal aortic arch artery development
Because the outflow tract did not move caudally with
respect to the aortic arch arteries in cardiac neural crest-
ablated embryos, we investigated how the aortic sac was
Fig. 7. Cardiac neural crest ablation disrupts the myocardial-smoothmuscle junction potentially impeding flow to the caudal arch arteries. Themyocardial-smooth
muscle junction is disrupted in cardiac neural crest-ablated embryos. (A–BV)Wholemount embryos in bright field (A and B) stainedwithMF20 (AV andBV, red) to
label the myocardium. (C–K) DIC images of sagittal sections with superimposed fluorescent MF20 staining (yellow). (A–BV) Bulges (asterisks in A and AV, and
arrows in B and BV) at the junction of the myocardium with the vascular smooth muscle of the aortic sac. (C) Section through a bulge (white arrow) consisting of
distal outflow tract myocardium and aortic sac mesenchyme and bordered dorsally by an indentation of the secondary heart field (green arrow). (D) Section
through a double bulge (white arrows) bordered dorsally by an indentation of the secondary heart field (green arrow) that meets the endoderm of third pharyngeal
pouch. (E) A series of indentations disrupt the myocardial/vascular smooth muscle junction and form a rippling appearance of the caudal wall of the aortic sac and
distal outflow tract myocardium. A major indentation (green arrow) pinches of the 4th and 6th arch arteries from the aortic sac by pushing against the third
pharyngeal pouch (P3). (F) The normal appearance of the distal caudal edge of the myocardium (arrow) when stained with MF20. (G) Abnormally displaced
MF20-positive cells (arrows) in a cardiac neural crest-ablated embryo (compare with the normal myocardial rim in F). (H) In the midsagittal part of the aortic sac,
myocardial cells are displaced abnormally to the roof of the aortic part of the aortic sac (arrows). (I) Clumps of myocardial cells (red arrow) bud into the pericardial
cavity. (J, K) The caudal wall of the aortic sac elongates in the sham embryo (K). In contrast, the caudal wall of the aortic sac in the cardiac neural crest ablated-
embryo (arrow in J) has not elongated and the myocardial cuff did not retract.
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endothelial cells and endothelial cell precursors (Coffin
and Poole, 1988), in sham-operated and cardiac neural crest-
ablated quail embryos in order to compare changes in aortic
sac shape and size.Normally, the aortic sac expands caudally as the caudal
aortic arch arteries become patent. The aortic sac of the
cardiac neural crest-ablated embryos did not expand caudally.
The lumen of the aortic sac was diminished in size proximo-
distally when compared to the sham-operated embryos (Figs.
Fig. 8. SM22 is differentially expressed in sham-operated versus neural crest-ablated embryos. Whole mount in situ hybridization at stage 27. (A–C) SM22
expression is higher on the right side in sham-operated embryos when compared to the left side. In contrast, SM22 is high on the left side in cardiac neural
crest-ablated embryos and persists in all the tissue surrounding the aortic sac (arrows in D–F). (G, H) Transverse sections of sham (G) and cardiac neural crest-
ablated (H) arterial poles showing that SM22 is expressed in all arch arteries (4, 6). In the sham-operated embryo, SM22 expression is higher in the lateral aortic
(Ao) wall (arrow in G) and lower in the lateral wall of the pulmonary trunk (PT). In the cardiac neural crest-ablated embryo both the aortic (A) and pulmonary
(P) (arrow in H) parts of the aortic sac express SM22 in their outside walls.
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arch arteries were diminished in size as they branched from
the narrowed aortic sac lumen (compare Figs. 10A with E).Fig. 9. Cardiac neural crest ablation disrupts the normal expression of vascular sm
pole. (A–D) Sagittal sections of the arterial pole stained with MF20 (red), and aSM
and aSMA. (E–H) Sagittal sections of the arterial pole stained with MF20 (red)
MLCK. At stage 24 (A, B) aSMA is normally expressed subendothelially in the ao
cardiac neural crest-ablated embryo it is ectopically expressed and disorganized ad
lumen of aortic sac. (C, D) At stage 28 the proximal walls of the sham pulmonary
of its walls were aSMA-negative. (E, F and G, H) MLCK expression is compared i
a photocomposite of two adjacent images of the same section). MLCK expression
crest-ablated embryos the anterior edge of the MLCK expression (arrow) in the roo
artery number. AS = aortic sac. * = aorticopulmonary septum.The aortic sac in cardiac neural crest-ablated embryos
remained close to the pharyngeal floor between stages 22
and 27 instead of becoming translocated ventrally toward theooth muscle markers MLCK and aSMA during development of the arterial
A (green or blue green) antibodies. Yellow indicates coexpression of MF20
or MLCK (green) antibodies. Yellow indicates coexpression of MF20 and
rtic sac (AS) of the sham (A) and neural crest-ablated embryo (B) but in the
jacent to the aortic sac (white and red arrows). Dotted line indicates closed
trunk (PT) express aSMA (arrows) even though in earlier stages these parts
n stage 26 sham (E, G) and cardiac neural crest-ablated (F, H) embryos (F is
is normal in the roof of the aortic sac and the pharyngeal floor but in neural
f of the aortic sac is positioned more cranial than normal. 3, 4, 6 = aortic arch
Fig. 10. The size of the aortic sac is diminished and growth towards the heart is delayed in the cardiac neural crest-ablated embryos. (A–H) Sagittal sections of
quail aortic sac and the distal outflow tract region stained with QH-1, a marker for quail endothelium and endothelial precursors. (I, J) DIC images of sagittal
sections stained with MF20 (yellow). The aortic sac of a sham-operated embryo (A–D) is compared with that of a cardiac neural crest-ablated embryo (E–H).
The lumen of the base of the arch arteries (3, 4, 6) as they branch from the aortic sac is greatly diminished in cardiac neural crest-ablated embryos (compare E
with A). The lumen of the distal part of the aortic sac (asterisk) of neural crest-ablated embryos is much shorter cranialcaudally and flattened ventrodorsally
(compare F with B, G with C, H with D). The lumen of the proximal part of the aortic sac (star in C, D, G, H) is also diminished (compare G with C, H with D).
(I, J) In the sham embryo (I), the mesenchyme between the roof of the aortic sac and the foregut endoderm (double-headed arrow) increases in volume, pushing
the aortic sac towards the heart. This does not occur in neural crest-ablated embryos (J) and the aortic sac stays close to the foregut floor.
K.L. Waldo et al. / Developmental Biology 281 (2005) 66–7774heart (Figs. 10I, J). As a result, the arch arteries were
shortened as a consequence of the retained constant distance
between the pharyngeal floor and the aortic sac.Discussion
Based on marking studies in cardiac neural crest-ablated
embryos, the myocardial component of the secondary heart
field failed to incorporate into the outflow tract and
stopped migration at the junction of the outflow tract with
the ventral pharynx. Although neural crest ablation
blocked production of myocardium by the secondary heart
field, it did not affect the production of a vascular smooth
muscle tunic for the arterial trunk (Fig. 11). The marking
study in cardiac neural crest-ablated embryos is direct
confirmation of an earlier observation by Yelbuz et al.
(2002) based on altered HNK1 expression that neural crest
ablation results in the shortened outflow tract due to the
failure of the addition of myocardium from the secondary
heart field. Since the Yelbuz et al. study, we have shown
that the secondary heart field gives rise to both myocar-
dium and arterial smooth muscle at the arterial pole
(Waldo et al., 2005). The present study shows that only the
myocardium from the secondary heart field is affected by
neural crest ablation. We show that the secondary heartfield cells undergo abnormal proliferation rather than
initiating migration into the outflow tract and differ-
entiating into myocardium.
Our results further show that cardiac neural crest
ablation causes cells in the secondary heart field to lose
their ability to migrate as a cohesive group. This is
reflected in the morphogenesis of the secondary heart field
epithelium. Normally, the secondary heart field is com-
prised of a pseudostratified epithelium that is distinctive
from surrounding tissue. In the neural crest ablated-
embryos, the secondary heart field epithelium is disorgan-
ized and the secondary heart field cells are displaced
inwardly, rather than being maintained in the same tissue
plane as the myocardium, as they migrate and incorporate
into the myocardium of the distal outflow. Preliminary data
in a separate study has shown that the secondary heart
field cells normally express Cx43, a protein associated
with cell migration in mice (Hutson et al., 2005). We
believe that the loss of Cx43 in the neural crest-ablated
secondary heart field may explain why the epithelium loses
its continuity.
Failure of the myocardial precursors to migrate from the
secondary heart field into the outflow tract at the appropriate
time resulted in ectopic myocardium that was displaced
inwardly toward the lumen of the aortic sac region and the
distal outflow tract where it formed bulges in the caudal
Fig. 11. Diagrammatic representation of the effects of cardiac neural crest ablation on the development of the arterial pole. Panels A and C are reprinted from
Waldo et al., (2005). See discussion for details.
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aortic sac mesenchyme. The indentations encroached on the
aortic sac and caudal pharyngeal pouches potentially
obstructing the blood flow from the aortic sac into the
caudalmost arch arteries. This could explain the randomized
patterning of the aortic arch arteries after neural crest
ablation (Bockman et al., 1987).
Another effect of cardiac neural crest ablation was the
failure of the outflow tract to translocate caudally as the
caudal aortic arch arteries opened. Because the outflow
tract did not move caudally, the distal aortic sac failed to
elongate caudally to connect with the caudal most aortic
arch arteries. As a result, the 4th and/or 6th arch arteries
were often missing, and alignment of the outflow tract with
the arch arteries was disturbed. In addition, cardiac neural
crest ablation resulted in abnormal proliferation that was
most pronounced in the secondary heart field but extended
to the myocardium during looping. We believe the increase
in proliferation is due to an excess of growth factor
signaling in the pharyngeal arches. We have recently shown
that FGF8 antibody can rescue many of the effects of
cardiac neural crest ablation including increased prolifer-
ation and that excessive FGF8 is responsible for increased
proliferation by the myocardium (Hutson et al., 2005;
Farrell et al., 2001). Interestingly, a recent publication by
Xu et al. (2004) shows that Tbx1 is expressed in mouse
secondary heart field where it regulates the cell prolifer-
ation, most likely mediated by FGF10, a direct target of
Tbx1, and possibly other FGFs. Tbx1 is a T-box tran-
scription factor that is located in the 22q11.2 locus.
Deletion of the 22q11.2 locus in humans causes DiGeorge
syndrome and is associated with outflow malalignment
defects, such as tetralogy of Fallot, and aortic arch artery
defects. In the mouse, loss of Tbx1 function causes
hypoproliferation in the secondary heart field and hypo-plasia of the outflow tract myocardium. This is in contrast
to neural crest ablation where we see hyperproliferation of
the secondary heart field and shortened outflow tract
myocardium.
An additional effect of cardiac neural crest ablation was
shortening of the aortic sac caused by the failure of the distal
myocardial edge to regress toward the heart. Due to absence
of cardiac neural crest cells, the mesenchyme between the
roof of the aortic sac and the pharyngeal floor did not
expand. As a result, normal translocation of the aortic sac
toward the heart and elongation of the aortic arch arteries
was delayed until stage 28. Fig. 11 summarizes many of the
effects of cardiac neural crest-ablation on the development
of the arterial pole.
Normal development of the secondary heart field
depends on appropriate levels of FGF signaling. Ablation
of cardiac neural crest, which causes a functional increase in
FGF signaling (Farrell et al., 2001; Hutson et al., 2005),
prevents normal addition of the myocardium from the
secondary heart field to the developing cardiac outflow
tract. The impact of this failure is that the looped tube is
shortened, which prevents convergence of the outflow and
inflow limbs, and ultimately results in failure of aortic
wedging between the mitral and tricuspid valves. In this
case the aorta overrides the ventricular septum and is called
dextroposed aorta (Hutson et al., 2005; Yelbuz et al., 2002).
This is one component in conotruncal defects such as
tetralogy of Fallot and double outlet right ventricle (Tomita
et al., 1991). In the neural crest-ablated embryo, the outflow
tract is not septated but the degree of wedging of the aortic
side of the persisting truncus can be ascertained, and the
truncus is most often not in correct alignment (Farrell et al.,
1999). Failure of addition of myocardium from the
secondary heart field is thus a potential mechanism for
genesis of these defects.
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crest could affect development of the secondary heart field
since the two fields of cells are not in direct contact (Waldo
et al., 1996). We now know that FGF8 signaling is critical
for addition of the secondary heart field to the outflow tract
because it can be rescued after neural crest ablation by
blocking FGF signaling to bring it to a more normal level
(Farrell et al., 2001; Hutson et al., 2005).
Arch artery patterning after neural crest ablation
We have previously documented abnormal persistence
and regression of the aortic arch arteries in neural crest-
ablated embryos (Bockman et al., 1987; Kirby et al., 1997).
The persistence and regression of the arch arteries has been
thought to be under the control of genetically encoded
patterning instructions (Kirby et al., 1997); however, our
current data showing hemodynamically challenged connec-
tions between the arch arteries, the aortic sac, and the
outflow tract make it possible that normal addition of the
secondary heart field and regression of the outflow tract
along the ventral pharynx could, in part, impact on arch
artery remodeling to the adult configuration. Interestingly,
FGF8 expressed by the pharyngeal ectoderm is also
important in genesis of the 4th arch artery (Macatee et al.,
2003). FGF8 signaling after neural crest ablation is
abnormal and so the abnormal patterning of the arch arteries
could be due to a variety of factors.
Thus, there are at least four reasons why the aortic arch
arteries may be abnormal after neural crest ablation. (1)
Absence of neural crest cells around the arch arteries may
make them unstable or may mean that patterning instruc-
tions are lacking (Kirby et al., 1997). (2) The FGF signaling
in the pharynx is excessive after neural crest ablation
(Farrell et al., 2001; Hutson et al., 2005). The Fgf8
hypomorphic mouse has abnormal patterning of the aortic
arch arteries and great arteries therefore the correct level
(not too much and not too little FGF8) may be critical for
arch artery patterning (Abu-Issa et al., 2002; Frank et al.,
2002; Macatee et al., 2003). (3) Because the outflow tract
does not move caudally as it should, the connection of the
outflow with the caudal arches is abnormal. (4) Reduction of
the size of the aortic sac and/or the abnormal myocardial
accumulation at junction of the outflow tract with the
myocardium could restrict blood flow or alter hemodynam-
ics at the junction of the outflow with the arch vessels
(Clark, 1986). It will be important to consider all of these
factors, which are not mutually exclusive, in determining
the etiology of arch artery patterning anomalies.Acknowledgments
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